Congress will probably pass a law next year that aims to improve the safety of mass market drugs like Vioxx. In this perspective published in PharmaDD, Dr. Nathan Goodman pleads with Congress to also include reforms that will provide faster access to drugs for seriously ill patients.

See Goodman's article in PharmaDD.